From Bench to Bedside: A Critical Appraisal of Somatostatin Receptor Antagonists in the Theranostic Management of Neuroendocrine Neoplasms.

Jafari E, Juweid ME, Raeisi A, Najdian A, Rekabpour SJ, Assadi M

Open source

DOI
10.2967/jnumed.126.272687
Published
2026 Sep 17
Container
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2967/jnumed.126.272687,
  title = {From Bench to Bedside: A Critical Appraisal of Somatostatin Receptor Antagonists in the Theranostic Management of Neuroendocrine Neoplasms.},
  author = {Jafari E and Juweid ME and Raeisi A and Najdian A and Rekabpour SJ and Assadi M},
  year = {2026},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  doi = {10.2967/jnumed.126.272687},
  url = {https://doi.org/10.2967/jnumed.126.272687}
}

RIS

TY  - JOUR
TI  - From Bench to Bedside: A Critical Appraisal of Somatostatin Receptor Antagonists in the Theranostic Management of Neuroendocrine Neoplasms.
AU  - Jafari E
AU  - Juweid ME
AU  - Raeisi A
AU  - Najdian A
AU  - Rekabpour SJ
AU  - Assadi M
PY  - 2026
JO  - Journal of nuclear medicine : official publication, Society of Nuclear Medicine
DO  - 10.2967/jnumed.126.272687
UR  - https://doi.org/10.2967/jnumed.126.272687
ER  - 

APA

E, J., ME, J., A, R., A, N., SJ, R., & M, A. (2026). From Bench to Bedside: A Critical Appraisal of Somatostatin Receptor Antagonists in the Theranostic Management of Neuroendocrine Neoplasms.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.126.272687

Source records